To assist patients in navigating this process, SWHR created the Migraine Patient Toolkit: A Guide to Your Care, a new resource that provides useful information about migraine diagnosis and treatment options, as well as tips on interacting with health care providers and health insurance companies to achieve the best possible outcomes.
The Society for Women’s Health Research announced the election of two new members to its Board of Directors: Dr. Linda G. Griffith, professor of biological engineering at the Massachusetts Institute of Technology (MIT), and Dr. Michael Ybarra, vice president of medical affairs and strategic alliances at the Pharmaceutical Research and Manufacturers of America (PhRMA).
“Dr. Griffith is an impassioned advocate for innovations in women’s health, as evidenced by her efforts to tackle difficult and understudied areas of women’s health research,” SWHR President and CEO Dr. Amy M. Miller said. “Dr. Ybarra’s expertise in partnership-building will greatly benefit SWHR as we look to collaborate with organizations whose missions align with our own. We are pleased that Dr. Griffith and Dr. Ybarra have agreed to join our Board to help further our work in eliminating imbalances in care for women.”
Griffith is a professor of biological engineering and director of the Center for Gynepathology Research at MIT. She received a bachelor’s degree from Georgia Tech and a PhD degree from the University of California at Berkeley, both in chemical engineering. She is a member of the National Academy of Engineering and the recipient of a MacArthur Foundation Fellowship.
Her research encompasses molecular-to-systems level analysis, design and synthesis of biomaterials, scaffolds, devices and micro-organs for a range of applications in regenerative medicine, tissue engineering, and in vitro drug development. A central theme is connecting the experimental systems to systems biology measurements. The Griffith lab leads a substantial program to build the “Human Physiome on a Chip,” funded by DARPA and NIH. In this program, 10 microphysiological systems, including liver, gut, lung, and reproductive systems, are interconnected in a physiologically relevant manner. Griffith is also a member of SWHR’s Estrogen-Driven Diseases Network as both an endometriosis patient and a researcher whose work in endometriosis has been recognized by NIH’s Office of Research on Women’s Health as well as the Endometriosis Foundation of America.
Ybarra is a board-certified emergency physician and vice president of medical affairs and strategic alliances at PhRMA, where he oversees outreach to stakeholder organizations on federal advocacy issues. He is a graduate of Stanford University and Georgetown University School of Medicine and completed his residency training in emergency medicine at MedStar Washington Hospital Center. In addition to his advocacy work, he continues to practice clinically in the emergency department at MedStar Georgetown University Hospital.
A full list of the SWHR Board of Directors is available here.
An SWHR working group published an expert review that identifies areas of need to improve a woman’s diagnosis, treatment, and access to quality care, as well as highlights priorities for the future of endometriosis research and care.
The Society for Women’s Health Research (SWHR) is pleased to announced the election of Alan Wright, MD, MPH, chief medical officer at Roche Diagnostics Corp., to its Board of Directors.
In an online survey developed by the Society for Women’s Health Research, a majority of school nurses reported that the pre-K-12 schools they work for do not have written policies on student bathroom use and do not have education for students and teachers on bladder health. Read More
A new SWHR report highlights how improving our knowledge about sex differences in cell biology in the female and male lower urinary tract may help stimulate breakthroughs in the diagnosis and management of urinary dysfunction for both women and men.
To decrease the substantial health and economic burden of migraine, researchers need to address how the disease differs between women and men, according to a report from the Society for Women’s Health Research published in the Journal of Women’s Health.
To prevent and treat Alzheimer’s disease, scientists need to better understand how the disease differs between women and men, according to a paper published June 12 in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.
SWHR will honor Janet Woodcock, MD, of the Food and Drug Administration, Christi Shaw of Eli Lilly and Co., and Colleen Conway-Welch, PhD, of the Vanderbilt University School of Nursing with the Health Visionary Award at its 28th Annual Awards Dinner on May 1 at the InterContinental Washington D.C. – The Wharf.
SWHR announced today the hiring of Emily Ortman as its new director of communications. Ortman will lead the development of strategic communications efforts to maximize the reach and impact of the Society’s scientific programs and policy activities. She will also oversee implementation of media relations, social media, and website content.